A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/513 (2006.01) A61K 31/44 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2622472
Pharmaceutical compositions comprising 2- [6- (3-Amino-piperidin-l-yl)-3- methyl-2, 4-dioxo-3, 4-dihydro-2H-pyrimidin-l-ylmethyl] -4-fluoro-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions. The compositions may be used for the treatment of diabetes.
L'invention concerne des compositions pharmaceutiques comprenant un 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile et des sels de celles-ci pharmaceutiquement acceptables ainsi que des trousses et des articles de production comprenant lesdites compositions pharmaceutiques et des méthodes d'utilisation de ces compositions pharmaceutiques. On peut utiliser lesdites compositions pour traiter le diabète.
Christopher Ronald J.
Covington Paul
Smart & Biggar
Takeda Pharmaceutical Company Limited
LandOfFree
Dipeptidyl peptidase inhibitors for treating diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipeptidyl peptidase inhibitors for treating diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase inhibitors for treating diabetes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2024983